Moreover, Chr-A reduced NADPH levels, further increased the accumulation of ROS and intracellular H2O2 and downregulated antioxidant proteins, including Nrf-2, HO-1 and NQO-1, to trigger oxidative stress and thus curb glioblastoma progression. Here, NFE2L2 is linked to glioblastoma.